Hanley K et al. |
Farnesol stimulates differentiation in epidermal keratinocytes via PPARalpha. |
2000 |
J. Biol. Chem. |
pmid:10753967
|
Beedle AM and Zamponi GW |
Block of voltage-dependent calcium channels by aliphatic monoamines. |
2000 |
Biophys. J. |
pmid:10866952
|
Mussoni L et al. |
Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells. |
2000 |
Thromb. Haemost. |
pmid:10928471
|
Mo H et al. |
Farnesyl anthranilate suppresses the growth, in vitro and in vivo, of murine B16 melanomas. |
2000 |
Cancer Lett. |
pmid:10936674
|
Hemmerlin A and Bach TJ |
Farnesol-induced cell death and stimulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in tobacco cv bright yellow-2 cells. |
2000 |
Plant Physiol. |
pmid:10938345
|
Toró A et al. |
Transannular Diels-Alder studies on the asymmetric total synthesis of chatancin: the pyranophane approach. |
2000 |
Org. Lett. |
pmid:10964353
|
Eskens FA et al. |
Farnesyl transferase inhibitors: current developments and future perspectives. |
2000 |
Cancer Treat. Rev. |
pmid:11006134
|
Kloog Y and Cox AD |
RAS inhibitors: potential for cancer therapeutics. |
2000 |
Mol Med Today |
pmid:11006529
|
Bringmann A et al. |
Farnesol modulates membrane currents in human retinal glial cells. |
2000 |
J. Neurosci. Res. |
pmid:11054809
|
Halaschek-Wiener J et al. |
A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cells. |
2000 |
Mol. Med. |
pmid:11055588
|